JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis, N Engl J Med, vol.356, pp.459-68, 2007. ,
Genomics of myeloproliferative neoplasms, J Clin Oncol, vol.35, pp.947-54, 2017. ,
JAK2 mutations are present in all cases of polycythemia vera, Leukemia, vol.22, pp.1289-1289, 2008. ,
JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis, Blood, vol.128, pp.839-51, 2016. ,
Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm, Leukemia, vol.31, pp.2122-2153, 2017. ,
STAT1 activation in association with JAK2 exon 12 mutations, Haematologica, vol.101, pp.15-19, 2015. ,
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations, Blood, vol.117, pp.2813-2819, 2011. ,
JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2 V617F mutated disease, Am J Hematol, vol.93, pp.93-96, 2018. ,
Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?, Leukemia, vol.22, pp.452-455, 2007. ,
Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia, Haematologica, vol.97, pp.1704-1711, 2012. ,
Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera, Leukemia, vol.21, pp.1960-1963, 2007. ,
Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients: correspondence, Br J Haematol, vol.142, pp.676-685, 2008. ,
Somatic mutations of JAK2 exon 12 in patients with JAK2 ,
, V617F)-negative myeloproliferative disorders, Blood, vol.111, pp.1686-1695, 2008.
High percentage of JAK2 exon 12 mutation in asian patients with polycythemia vera, Am J Clin Pathol, vol.134, pp.266-70, 2010. ,
JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics, Blood Adv, vol.1, pp.968-71, 2017. ,
The evolutionary history of 2,658 cancers, Nature, vol.578, pp.122-130, 2020. ,
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks, Stat Med, vol.32, pp.5381-97, 2013. ,
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study, Leukemia, vol.27, pp.1874-81, 2013. ,
Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations, Am J Clin Pathol, vol.133, pp.942-950, 2010. ,